Company Profile: Amyris

Engineering microbes to produce high-value chemical products

The full version of this company profile is available to members of:

Accelerating Materials Innovation
Alternative Fuels
Bio-based Materials and Chemicals
Consumer Choices in Food, Health, and Wellness
Owning the Energy Transition

Categories	Bio-based specialty chemical products, Bio-derived polymers, Drop-in BBMC products, Fermentation, Sugar / starch feedstocks
Competitors	OPX Biotechnologies, Verdezyne, Solazyme, Neste, Dynamic Fuels, Allylix, Algenol, Parabel, Solix BioSystems, BlackGold Biofuels, LS9, Seambiotic, Bionavitas, OriginClear, Genomatica, Nucelis, Intrexon
Relationships	Total (Investor) Procter and Gamble (P&G) (Development partner) + 81 additional customers, development partners, distributors, investors, joint venture partners, subsidiaries, and suppliers. Sign in to view

Strategy & Markets

Amyris uses a high-throughput screening process to evaluate various genetically engineered strains of yeast that...

Related Research

Date	Type	Title
May 29, 2018	Technology	Synthetic Biology
May 24, 2018	Case Study	Amyris brought its farnesene production platform to scale, but returned to low-volume applications following financial trouble
May 2, 2018	Analyst Insight	Biojet Fuel Technology Update: 2018 edition
March 29, 2018	Analyst Insight	Can microbes beat out plants, insects, and sharks for the commercial production of terpenes?
December 7, 2017	Analyst Insight	BBMC 2017 Year in Review
August 3, 2017	Analyst Insight	Lux highlights the key themes from BIO World Congress 2017
April 4, 2017	Analyst Insight	Takeoff: Can LCFS credits offset biojet fuels' price premium?
March 16, 2017	Analyst Insight	The race for bio-based tire additives: Amyris and Kuraray come out in front
January 5, 2017	Analyst Insight	Bio-based polymers to be a key BBMC opportunity in 2017
December 8, 2016	Analyst Insight	2016 BBMC roundup and what you can’t miss going into 2017
December 5, 2016	State of the Market Report	Show Me the Money: Where Is Venture Capital Placing Bets in Bio-based?
September 6, 2016	Analyst Insight	For sale: One of these three companies will buy Abengoa's Hugoton plant next month
September 1, 2016	Analyst Insight	CJ CheilJedang Corporation purchases Metabolix's PHA assets for $10 million
August 23, 2016	Analyst Insight	U.S. DOE goes two for three at the plate with MEGA-BIO project funding
August 4, 2016	Analyst Insight	Metabolix ending biopolymer operations and rebranding as Yield10 Bioscience to focus on crop improvement technology
June 30, 2016	State of the Market Report	Hunting For Value And Performance In The Bio-based Materials And Chemicals Space
June 23, 2016	Analyst Insight	In search of performance from biomass
June 14, 2016	Analyst Insight	Cathay Pacific continues its biojet initiatives with two-year supply agreement with Amyris
June 9, 2016	Analyst Insight	Personal care and cosmetics continues to be a growth driver for bio-based materials and chemicals, as Amyris signs an MOU with CJ CheilJedang
May 6, 2016	State of the Market Report	Biojet Fuel Technology Roadmap
March 17, 2016	Analyst Insight	Solazyme rebrands as TerraVia; throws in the towel for the production of industrial oils
March 8, 2016	Analyst Insight	Lux Take two: Revisiting the potential of key alternative fuels technologies
February 11, 2016	State of the Market Report	Alternative Fuels Year in Review:The Five Biggest Developments of 2015, and Five to Watch in 2016 and Beyond
January 31, 2016	State of the Market Report	Bio-based Materials and Chemicals in Review: Key Trends in 2015 and What to Watch in 2016
January 12, 2016	State of the Market Report	0 to 100: The Rapidly Accelerating Future of Automotive Efficiency
October 29, 2015	Analyst Insight	Amyris' commercialization of B2C product potentially improves the company's profit margin
August 4, 2015	State of the Market Report	Betting Big in Bio-Based: How to Leverage Evolving Trends and Hedge Against Uncertainty
July 28, 2015	Analyst Insight	Biojet news roundup: Investments, partnerships, and roadmaps towards commercial biojet fuel production
July 28, 2015	Analyst Insight	Amyris' entry into the food industry continues the trend of the shift towards higher value applications
July 13, 2015	Analyst Insight	Biojet fuel, advanced coatings, and TIPV provide near-term solutions for sustainable aviation
May 14, 2015	Analyst Insight	Taking stock: Amyris, Solazyme, BioAmber, and Gevo spent Q1 2015 expanding market opportunities
March 10, 2015	Analyst Insight	Amidst cheap oil, Total invests in Renmatix for biomass to sugars
February 24, 2015	Analyst Insight	Sapphire Energy shifting focus away from biofuels
January 22, 2015	Analyst Insight	Bio-based materials and chemicals in review: Key trends in 2014 and what to watch in 2015
December 2, 2014	Analyst Insight	U.S. ethanol producers hit blend wall, shift to biochemicals
November 13, 2014	Analyst Insight	Amyris, Solazyme recipients of the 2014 EPA Presidential Green Chemistry Challenge Awards
September 18, 2014	Analyst Insight	A way forward for isoprene production, as Braskem joins existing Amyris and Michelin partnership
August 7, 2014	Analyst Insight	Evonik invests in Biosynthetic Technologies, as confidence in biolubricants increases
July 1, 2014	Analyst Insight	ASTM approves DSHC process for jet fuel, opening the door for Amyris and Total's farnesene JV
June 17, 2014	Analyst Insight	Brazil alternative fuels' government support expands a 40-year-old infrastructure
May 6, 2014	Analyst Insight	GreenSky announces location for commercial jet facility, but delays in overall biojet growth anticipated
March 11, 2014	Analyst Insight	Comparing feedstock needs of bio-based chemicals and biofuels
March 6, 2014	Analyst Insight	Amyris expands specialty chemical business, but fuels focus doesn't seem to be going away
December 12, 2013	Analyst Insight	Green Biologics receives investment, continues to progress
November 14, 2013	Analyst Insight	Q3 2013 report roundup -- Gevo, Amyris, and Solazyme disclose financials and make announcements
October 17, 2013	Analyst Insight	Amyris hits production milestone, but full commercial scale still far off
September 19, 2013	Analyst Insight	Recapping the reunion: Maturing bio-based chemicals developers take stock
September 5, 2013	Analyst Insight	The retrofit model employed again as Blue Marble Biomaterials buys site for next biorefinery
April 18, 2013	Analyst Insight	Sanofi produces partially-synthetic artemisinin in "large quantities" with Amyris pathway
April 4, 2013	Analyst Insight	Amyris announces string of accomplishments on funding and strategic partnership in fragrance and flavors
October 4, 2012	Analyst Insight	Amyris details product lineup, though pricing may still be too high to drive torrent of demand
July 3, 2012	Analyst Insight	Solazyme and Bunge begin construction on renewable oils facility in Brazil
May 3, 2012	Analyst Insight	“Shake up” at Amyris more an indication of a desperate partner hungry to grow demand
April 10, 2012	Analyst Insight	Feedstocks on the mind at the Advanced Biofuels Summit
February 14, 2012	Analyst Insight	Enerkem files for IPO, challenging the market's appetite for alt fuel investments
February 14, 2012	Analyst Insight	Bumpy road continues for biofuel producers, as Amyris downscales targets, CHOREN sells technology
December 6, 2011	Analyst Insight	Biojet news roundup: FAA distributes $7.7 million in grants; Amyris/Total form JV; AliphaJet and Honeywell sign MOU
November 22, 2011	Analyst Insight	In surprise move, Qteros CEO McCarthy leaves in round of layoffs
November 17, 2011	Analyst Insight	Busy time for transactions in BBMC: Amyris, Draths, TetraVitae, and BioAmber do deals
October 6, 2011	Analyst Insight	Bio-based synthetic rubber almost ready to hit the road, but not too late to join the race
September 22, 2011	Analyst Insight	Elevance and Mascoma step up to the IPO dinner table: feast or famine?
September 8, 2011	Analyst Insight	Seeking a green premium, bio-based developers turn to cosmetics
August 30, 2011	Analyst Insight	Bold U.S. government biofuels plans generate needed momentum for industry
August 11, 2011	Analyst Insight	Bio-based partnering round-up: Metabolix/CJ, Kuraray/Amyris, and AkzoNobel/Boxing Oleochemicals
August 9, 2011	Analyst Insight	Materials suppliers follow consumer brand owners into synthetic biology
July 28, 2011	Analyst Insight	Elevance gains steam through partnerships, funding, and acquisition
July 28, 2011	Analyst Insight	Global Bioenergies's small IPO: Size is not what matters
June 2, 2011	Analyst Insight	Billion-dollar bio-based chemicals IPO window is open, as Solazyme IPOs and Myriant files
April 26, 2011	Analyst Insight	KiOR files for $100 million IPO: How long will the biofuels IPO window stay open?
April 26, 2011	Analyst Insight	Insights from the Advanced Biofuels Leadership Conference
March 29, 2011	Analyst Insight	Solazyme files for IPO
February 10, 2011	Analyst Insight	Gevo raises $107 million in its IPO as synbio stays in the spotlight
December 7, 2010	Analyst Insight	Downscaling of EPA’s cellulosic ethanol mandate illustrates value of multiple-option strategic planning
November 9, 2010	Analyst Insight	Cobalt Technologies partners with the U.S. Navy to develop bio-jet and biodiesel fuels
November 9, 2010	Analyst Insight	Tate & Lyle and Roquette take synthetic biology further into food, personal care, and agriculture
October 12, 2010	Analyst Insight	Amyris completes $84.8 million IPO, no effect on other, less qualified, IPO hopefuls
July 6, 2010	Analyst Insight	Preparing for IPO, Amyris announces a flurry of activity
May 25, 2010	Analyst Insight	Original syn: debate over definition of first synthetic life presages commercial and IP battles
April 27, 2010	Analyst Insight	Codexis knocks out $78 million IPO; Amyris up to bat with Gevo on deck
March 30, 2010	Analyst Insight	Genomatica raises Series C
January 5, 2010	Analyst Insight	Eyeing a better 2010, Codexis re-files for IPO
December 8, 2009	Analyst Insight	EPA dithering on ethanol blend limits whacks corn ethanol producers
September 1, 2009	Analyst Insight	Artificial life by the end of the year to touch off synbio debate
August 25, 2009	Analyst Insight	Amyris bags another $24.7 million in Series C; synthetic biology gets another boost
January 13, 2009	Analyst Insight	Synthetic biology tackles energy needs at JBEI
December 9, 2008	Analyst Insight	(Watch)dog bites man: ETC Group fails synthetic biology debate

Last Update: October 30, 2018

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Interested in Learning More?

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978